ALS (Lou Gehrig's Disease) clinical trials in Texas
16 active ALS (Lou Gehrig's Disease) trials with a site in Texas. Describe your situation to see which ones look like a fit.
- Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
- Study of COYA 302 for the Treatment of ALS
- AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
- Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
- PREVENT ALL ALS Study
- ASSESS ALL ALS Study
- Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
- Clinical Procedures to Support Research in ALS
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
- INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study
- MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System
- BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration
- HEALEY ALS Platform Trial - Master Protocol
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.